Inhibition of macrophage activation by the myxoma virus M141 protein (vCD200)

J Virol. 2009 Sep;83(18):9602-7. doi: 10.1128/JVI.01078-09. Epub 2009 Jul 1.

Abstract

The M141 protein of myxoma virus (MYXV) is a viral CD200 homolog (also called vOX-2) that inhibits macrophage activation in infected rabbits. Here, we show that murine myeloid RAW 264.7 cells became activated when infected with MYXV in which the M141 gene was deleted (vMyx-M141KO) but not with the parental wild-type MYXV. Moreover, transcript and protein levels of tumor necrosis factor and granulocyte colony-stimulating factor were rapidly upregulated in an NF-kappaB-dependent fashion in the RAW 264.7 cells infected with vMyx-M141KO. M141 protein is present in the virion and counteracts this NF-kappaB activation pathway upon infection with the wild-type MYXV. Our data suggest that upregulation of these classic macrophage-related proinflammatory cytokine markers following infection of myeloid cells with the M141-knockout MYXV is mediated via the rapid activation of the cellular NF-kappaB pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD
  • Cell Line
  • Granulocyte Colony-Stimulating Factor / genetics
  • Macrophage Activation / immunology*
  • Macrophages / virology*
  • Mice
  • Myeloid Cells / virology
  • Myxoma virus / immunology*
  • Myxoma virus / pathogenicity
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism
  • Tumor Necrosis Factor-alpha / genetics
  • Up-Regulation
  • Viral Proteins / physiology*

Substances

  • Antigens, CD
  • M141R protein, myxoma virus
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • Viral Proteins
  • Granulocyte Colony-Stimulating Factor
  • antigens, CD200